| Autor: |
Shu-Han Lin, Donna, Tzeng, Shian Chiuan, Cha, Tai-Lung, Hung, Chin-Mao, Lin, Wen-Chin, Yang, Chuen-Mi, Lu, Hsuan-Ying, Chang, Jia-Yu, Huang, Shu-Wei |
| Zdroj: |
Journal of Microbiology, Immunology and Infection; 20230101, Issue: Preprints |
| Abstrakt: |
Effective therapy for COVID-19 remains limited. Hydroxychloroquine (HCQ) has been considered, but safety and efficacy concerns remain. Chitosan exhibits antiviral and immunomodulatory effects, yet how the combination of HCQ and chitosan performs in treating COVID-19 is unknown. |
| Databáze: |
Supplemental Index |
| Externí odkaz: |
|
